| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,574 |
5,215 |
$443.63 |
| 59025 |
Fetal non-stress test |
123 |
40 |
$0.00 |
| 86038 |
|
87 |
86 |
$0.00 |
| 84439 |
|
259 |
258 |
$0.00 |
| 80061 |
Lipid panel |
2,170 |
2,163 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
299 |
297 |
$0.00 |
| 99173 |
|
620 |
618 |
$0.00 |
| 90734 |
|
199 |
199 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
149 |
147 |
$0.00 |
| 3046F |
|
96 |
96 |
$0.00 |
| 81002 |
|
1,045 |
952 |
$0.00 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,108 |
1,018 |
$0.00 |
| 3078F |
|
161 |
155 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,069 |
1,959 |
$0.00 |
| 80076 |
|
192 |
183 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
214 |
214 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
674 |
656 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
87 |
86 |
$0.00 |
| 90700 |
|
37 |
37 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
454 |
453 |
$0.00 |
| 86480 |
|
160 |
158 |
$0.00 |
| T4541 |
Incontinence product, disposable underpad, large, each |
246 |
238 |
$0.00 |
| 90710 |
|
95 |
95 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
210 |
208 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
491 |
489 |
$0.00 |
| 81025 |
|
736 |
700 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,782 |
692 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
881 |
874 |
$0.00 |
| 91300 |
|
110 |
107 |
$0.00 |
| 87186 |
|
248 |
244 |
$0.00 |
| 90715 |
|
257 |
257 |
$0.00 |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
46 |
27 |
$0.00 |
| 86696 |
|
81 |
81 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
368 |
366 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
240 |
239 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
414 |
414 |
$0.00 |
| 85007 |
|
90 |
88 |
$0.00 |
| J9035 |
Injection, bevacizumab, 10 mg |
74 |
63 |
$0.00 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
93 |
93 |
$0.00 |
| 85610 |
|
39 |
39 |
$0.00 |
| 82947 |
|
260 |
247 |
$0.00 |
| 83540 |
|
109 |
108 |
$0.00 |
| 86900 |
|
108 |
106 |
$0.00 |
| 82542 |
|
54 |
54 |
$0.00 |
| 84550 |
|
157 |
156 |
$0.00 |
| 99072 |
|
660 |
427 |
$0.00 |
| 97163 |
|
45 |
45 |
$0.00 |
| 67028 |
Intravitreal injection of a pharmacologic agent |
28 |
24 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
94 |
94 |
$0.00 |
| 82652 |
|
92 |
90 |
$0.00 |
| 4004F |
|
186 |
183 |
$0.00 |
| 81003 |
|
84 |
76 |
$0.00 |
| 99233 |
Prolong inpt eval add15 m |
391 |
159 |
$0.00 |
| 86431 |
|
53 |
51 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
518 |
491 |
$0.00 |
| 80074 |
|
119 |
118 |
$0.00 |
| 76813 |
|
72 |
72 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
145 |
140 |
$0.00 |
| 92134 |
|
47 |
45 |
$0.00 |
| 93224 |
|
40 |
40 |
$0.00 |
| J0135 |
Injection, adalimumab, 20 mg |
66 |
65 |
$0.00 |
| 87660 |
|
211 |
211 |
$0.00 |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
212 |
209 |
$0.00 |
| 87806 |
|
139 |
139 |
$0.00 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
151 |
119 |
$0.00 |
| 83655 |
|
84 |
83 |
$0.00 |
| 94664 |
|
99 |
99 |
$0.00 |
| 97803 |
|
27 |
27 |
$0.00 |
| G9905 |
Patient not screened for tobacco use |
180 |
177 |
$0.00 |
| A4595 |
Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes) |
71 |
70 |
$0.00 |
| 86708 |
|
24 |
24 |
$0.00 |
| 82570 |
|
315 |
313 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
91 |
91 |
$0.00 |
| 99223 |
Prolong inpt eval add15 m |
193 |
184 |
$0.00 |
| 82565 |
|
86 |
81 |
$0.00 |
| 90707 |
|
78 |
78 |
$0.00 |
| 90633 |
|
216 |
216 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
60 |
60 |
$0.00 |
| 84450 |
|
38 |
38 |
$0.00 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
34 |
34 |
$0.00 |
| 99188 |
|
195 |
195 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
13 |
12 |
$0.00 |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
12 |
12 |
$0.00 |
| 90648 |
|
26 |
26 |
$0.00 |
| 99053 |
|
16 |
16 |
$0.00 |
| 84460 |
|
38 |
38 |
$0.00 |
| 99401 |
|
169 |
157 |
$0.00 |
| 82274 |
|
124 |
124 |
$0.00 |
| 84702 |
|
111 |
94 |
$0.00 |
| G8785 |
Blood pressure reading not documented, reason not given |
157 |
150 |
$0.00 |
| 90736 |
|
16 |
16 |
$0.00 |
| 90670 |
|
230 |
226 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
82 |
81 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
77 |
77 |
$0.00 |
| 92552 |
|
131 |
131 |
$0.00 |
| 84156 |
|
29 |
26 |
$0.00 |
| 0002A |
|
12 |
12 |
$0.00 |
| 99222 |
Initial hospital care, per day, moderate complexity |
77 |
75 |
$0.00 |
| G9920 |
Screening performed and negative |
87 |
87 |
$0.00 |
| 80299 |
|
53 |
53 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
49 |
49 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
45 |
45 |
$0.00 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13 |
13 |
$0.00 |
| 3077F |
|
43 |
43 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
51 |
50 |
$0.00 |
| 70450 |
Computed tomography, head or brain; without contrast material |
16 |
14 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
20 |
20 |
$0.00 |
| 87481 |
|
82 |
82 |
$0.00 |
| 87653 |
|
13 |
13 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
40 |
40 |
$0.00 |
| 95144 |
|
77 |
34 |
$0.00 |
| 87902 |
|
12 |
12 |
$0.00 |
| R0075 |
Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen |
27 |
26 |
$0.00 |
| 1159F |
|
28 |
24 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
349 |
343 |
$0.00 |
| 90649 |
|
40 |
40 |
$0.00 |
| H1000 |
Prenatal care, at-risk assessment |
14 |
14 |
$0.00 |
| 90750 |
|
13 |
13 |
$0.00 |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
34 |
34 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
13 |
13 |
$0.00 |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
16 |
16 |
$0.00 |
| 95811 |
|
23 |
13 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |
| 82248 |
|
12 |
12 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
298 |
296 |
$0.00 |
| 94010 |
|
286 |
273 |
$0.00 |
| 92551 |
|
456 |
455 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
698 |
697 |
$0.00 |
| 85027 |
|
329 |
221 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
474 |
414 |
$0.00 |
| 90744 |
|
108 |
106 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
610 |
588 |
$0.00 |
| 90716 |
|
110 |
110 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
875 |
869 |
$0.00 |
| H2000 |
Comprehensive multidisciplinary evaluation |
30 |
26 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,885 |
724 |
$0.00 |
| 81001 |
|
798 |
781 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,402 |
2,392 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,718 |
2,405 |
$0.00 |
| T4535 |
Disposable liner/shield/guard/pad/undergarment, for incontinence, each |
83 |
82 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
470 |
225 |
$0.00 |
| 82728 |
|
99 |
98 |
$0.00 |
| 86140 |
|
143 |
141 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,183 |
10,335 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
356 |
338 |
$0.00 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
215 |
204 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
186 |
175 |
$0.00 |
| 86141 |
|
15 |
15 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
42 |
42 |
$0.00 |
| 99000 |
|
387 |
386 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,614 |
2,492 |
$0.00 |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
222 |
217 |
$0.00 |
| 3008F |
|
414 |
409 |
$0.00 |
| 85018 |
|
860 |
858 |
$0.00 |
| 86803 |
|
366 |
363 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,593 |
1,587 |
$0.00 |
| 94200 |
|
1,045 |
555 |
$0.00 |
| 84153 |
|
84 |
83 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
271 |
271 |
$0.00 |
| 96156 |
|
288 |
251 |
$0.00 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
309 |
307 |
$0.00 |
| 83789 |
|
54 |
54 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
121 |
118 |
$0.00 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
530 |
182 |
$0.00 |
| 85652 |
|
168 |
165 |
$0.00 |
| 82607 |
|
315 |
314 |
$0.00 |
| 84484 |
|
51 |
45 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
13 |
13 |
$0.00 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
327 |
128 |
$0.00 |
| 96127 |
|
85 |
85 |
$0.00 |
| 88142 |
|
20 |
20 |
$0.00 |
| 86481 |
|
76 |
76 |
$0.00 |
| 83550 |
|
104 |
103 |
$0.00 |
| 94760 |
|
505 |
467 |
$0.00 |
| 86901 |
|
108 |
106 |
$0.00 |
| 80055 |
|
86 |
85 |
$0.00 |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
1,010 |
711 |
$0.00 |
| 82043 |
|
566 |
564 |
$0.00 |
| 92250 |
|
133 |
132 |
$0.00 |
| 1157F |
|
54 |
47 |
$0.00 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
441 |
339 |
$0.00 |
| 86704 |
|
24 |
24 |
$0.00 |
| 82746 |
|
281 |
280 |
$0.00 |
| 95117 |
|
955 |
491 |
$0.00 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
77 |
77 |
$0.00 |
| 86780 |
|
93 |
92 |
$0.00 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
242 |
112 |
$0.00 |
| 87088 |
|
48 |
46 |
$0.00 |
| 97014 |
|
274 |
102 |
$0.00 |
| 87510 |
|
213 |
213 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
73 |
53 |
$0.00 |
| 93000 |
|
307 |
306 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
70 |
70 |
$0.00 |
| 86706 |
|
48 |
48 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
206 |
206 |
$0.00 |
| 87077 |
|
118 |
117 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
243 |
235 |
$0.00 |
| 87480 |
|
213 |
213 |
$0.00 |
| 86592 |
|
339 |
338 |
$0.00 |
| G9745 |
Documented reason for not screening or recommending a follow-up for high blood pressure |
251 |
247 |
$0.00 |
| 3080F |
|
34 |
34 |
$0.00 |
| 86580 |
|
49 |
48 |
$0.00 |
| 0011A |
|
59 |
59 |
$0.00 |
| 3044F |
|
62 |
62 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
106 |
94 |
$0.00 |
| 83735 |
|
206 |
101 |
$0.00 |
| G8430 |
Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) |
333 |
327 |
$0.00 |
| 1000F |
|
13 |
13 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
414 |
412 |
$0.00 |
| 82962 |
|
334 |
331 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
213 |
204 |
$0.00 |
| 91301 |
|
183 |
181 |
$0.00 |
| 82950 |
|
105 |
105 |
$0.00 |
| 87340 |
|
103 |
102 |
$0.00 |
| J3590 |
Unclassified biologics |
44 |
43 |
$0.00 |
| 3074F |
|
196 |
189 |
$0.00 |
| 92567 |
|
15 |
15 |
$0.00 |
| 85013 |
|
12 |
12 |
$0.00 |
| 90680 |
|
68 |
67 |
$0.00 |
| A4335 |
Incontinence supply; miscellaneous |
12 |
12 |
$0.00 |
| 20610 |
|
78 |
41 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
13 |
12 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
193 |
192 |
$0.00 |
| 97802 |
|
28 |
28 |
$0.00 |
| J3490 |
Unclassified drugs |
332 |
297 |
$0.00 |
| 90651 |
|
160 |
160 |
$0.00 |
| 82550 |
|
45 |
45 |
$0.00 |
| 3079F |
|
89 |
88 |
$0.00 |
| 90698 |
|
148 |
144 |
$0.00 |
| 44361 |
|
13 |
13 |
$0.00 |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
88 |
88 |
$0.00 |
| 86762 |
|
92 |
91 |
$0.00 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
16 |
15 |
$0.00 |
| 0012A |
|
118 |
118 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
68 |
68 |
$0.00 |
| 1036F |
|
251 |
243 |
$0.00 |
| 3075F |
|
25 |
24 |
$0.00 |
| 3017F |
|
256 |
250 |
$0.00 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
159 |
151 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
67 |
49 |
$0.00 |
| 99406 |
|
15 |
15 |
$0.00 |
| 83001 |
|
25 |
24 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
38 |
38 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
54 |
54 |
$0.00 |
| 80050 |
General health panel |
33 |
33 |
$0.00 |
| 86850 |
|
109 |
107 |
$0.00 |
| 83690 |
|
59 |
57 |
$0.00 |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
13 |
13 |
$0.00 |
| 90696 |
|
101 |
101 |
$0.00 |
| 87081 |
|
13 |
13 |
$0.00 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
13 |
13 |
$0.00 |
| Q0092 |
Set-up portable x-ray equipment |
28 |
27 |
$0.00 |
| 99460 |
|
26 |
26 |
$0.00 |
| 90688 |
|
14 |
13 |
$0.00 |
| 99462 |
|
19 |
15 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
19 |
19 |
$0.00 |
| 51798 |
|
14 |
14 |
$0.00 |